Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6
- PMID: 11877294
- DOI: 10.1182/blood.v99.6.2172
Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6
Abstract
Specific intracellular signals mediated by interleukin-6 (IL-6) receptor complexes, such as signal transducer and activator of transcription 3 (STAT 3) and extracellular signal-regulated kinase (ERK) 1/2, are considered to be responsible for inducing a variety of cellular responses. In multiple myeloma, IL-6 only enhanced the proliferation of CD45+ tumor cells that harbored the IL-6-independent activation of src family kinases even though STAT3 and ERK1/2 could be activated in response to IL-6 in both CD45+ and CD45(minus sign) cells. Furthermore, the IL-6-induced proliferation of CD45+ U266 myeloma cells was significantly suppressed by Lyn-specific antisense oligodeoxynucleotides or a selective src kinase inhibitor. These results indicate that the activation of both STAT3 and ERK1/2 is not enough for IL-6-induced proliferation of myeloma cell lines that require src family kinase activation independent of IL-6 stimulation. Thus, the activation of the src family kinases associated with CD45 expression is a prerequisite for the proliferation of myeloma cell lines by IL-6. We propose a mechanism for IL-6-induced cell proliferation that is strictly dependent upon the cellular context in myelomas.
Similar articles
-
The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.Int J Hematol. 2004 Jan;79(1):63-73. doi: 10.1007/BF02983536. Int J Hematol. 2004. PMID: 14979481
-
Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.Leuk Lymphoma. 2003 Sep;44(9):1477-81. doi: 10.3109/10428190309178767. Leuk Lymphoma. 2003. PMID: 14565647 Review.
-
Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules.Int J Hematol. 2003 Aug;78(2):95-105. doi: 10.1007/BF02983376. Int J Hematol. 2003. PMID: 12953802 Review.
-
Growth mechanism of human myeloma cells by interleukin-6.Int J Hematol. 2002 Aug;76 Suppl 1:329-33. doi: 10.1007/BF03165278. Int J Hematol. 2002. PMID: 12430875
-
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.J Immunol. 1997 Sep 1;159(5):2212-21. J Immunol. 1997. PMID: 9278309
Cited by
-
The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.Int J Hematol. 2004 Jan;79(1):63-73. doi: 10.1007/BF02983536. Int J Hematol. 2004. PMID: 14979481
-
Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.Blood. 2005 May 15;105(10):3987-94. doi: 10.1182/blood-2004-07-2781. Epub 2005 Jan 21. Blood. 2005. PMID: 15665117 Free PMC article.
-
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.Theranostics. 2022 Jan 16;12(4):1715-1729. doi: 10.7150/thno.54453. eCollection 2022. Theranostics. 2022. PMID: 35198065 Free PMC article.
-
[Expression of CD45 in newly diagnosed multiple myeloma and the relationship with prognosis].Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):744-749. doi: 10.3760/cma.j.issn.0253-2727.2019.09.006. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31648475 Free PMC article. Chinese.
-
Logic programming reveals alteration of key transcription factors in multiple myeloma.Sci Rep. 2017 Aug 23;7(1):9257. doi: 10.1038/s41598-017-09378-9. Sci Rep. 2017. PMID: 28835615 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous